Metformin Treatment is Associated with Reduced Risk of Hypoglycaemia, Major Adverse Cardiovascular Events, and All-Cause Mortality in Patients with Post-pancreatitis Diabetes Mellitus: A Nationwide Cohort Study.
Line DavidsenMorten H JensenMathias E CookPeter VestergaardFilip K Krag KnopAsbjørn M DrewesSøren S OlesenPublished in: European journal of endocrinology (2023)
Metformin is associated with a lower risk of adverse outcomes, including all-cause mortality in patients with PPDM, supporting the use of metformin as a glucose-lowering therapy for these patients.